Andrew Firlik, M.D., General Partner, Foundation Medical Partners. Dr. Firlik joined Foundation Medical Partners in 2005 to concentrate on medical device and biopharmaceutical investments. Prior to Foundation, he was a venture partner at Sprout Group and a managing director of its healthcare technology spinout, New Leaf Venture Partners. Previously, he was a principal at Canaan Partners. Dr. Firlik has led investments and served on the board of directors of many early stage companies. He is a co-founder and inventor of the core technology platform of Northstar Neuroscience (Nasdaq: NSTR), a medical device company that is currently in clinical trials of a neuromodulation technology. Dr. Firlik is the Chairman of NovaVision, a medical therapeutics firm focusing on neuroplasticity for visual disorders. He currently serves on the board of directors of NeuroVista, SpineWave, BridgePoint Medical, Vertos, Visiogen, SetPoint Medical and Intelect Medical. Dr. Firlik is a member of the Cornell University Council. He studied biology at Cornell University and Oxford University, received his MBA from the Katz Graduate School of Business at the University of Pittsburgh, and his M.D. from Cornell University Medical College. Dr. Firlik is a board certified neurosurgeon and has published numerous scientific articles in the field.